<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Red Blood Cell Disorders | Fundamentals of Pathology</title>
<!-- Preconnect for performance -->
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>

<!-- Google Fonts -->
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">

<!-- Main Stylesheet -->
<link rel="stylesheet" href="../styles/main.css">

<!-- MathJax Configuration -->
<script>
MathJax = {
    tex: {
        inlineMath: [['$', '$'], ['\\(', '\\)']],
        displayMath: [['$$', '$$'], ['\\[', '\\]']],
        processEscapes: true,
        processEnvironments: true,
        tags: 'ams'
    },
    svg: { fontCache: 'global' },
    options: {
        skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
    }
};
</script>
<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
<!-- Reading Progress Bar -->
<div class="reading-progress-container" aria-hidden="true">
    <div class="reading-progress-bar" id="reading-progress"></div>
</div>

<!-- Theme Toggle -->
<button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
    <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
    <span class="theme-toggle-icon dark-icon">üåô</span>
</button>

<div class="page-wrapper">
    <!-- Floating Mini-TOC -->
    <aside class="floating-toc" id="floating-toc" aria-label="On this page">
        <div class="floating-toc-header">
            <span class="floating-toc-icon">üìë</span>
            <span>On this page</span>
        </div>
        <nav class="floating-toc-nav">
            <ul class="floating-toc-list">
                <!-- Populated by JS -->
            </ul>
        </nav>
    </aside>

    <div class="container">
        <article class="document-article" role="main" id="main-content">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document navigation">
                <div class="nav-container">
                    <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                        <span class="nav-icon">üìö</span>
                        <span class="nav-text">Contents</span>
                    </a>
                    
                    <a href="chapter-04-hemostasis.html" class="nav-button nav-button--prev" aria-label="Previous section">
                        <span class="nav-icon">‚Üê</span>
                        <span class="nav-text">Previous</span>
                    </a>
                    
                    <div class="document-progress">
                        <div class="progress-indicator">
                            <span class="progress-current">5</span>
                            <span class="progress-separator">/</span>
                            <span class="progress-total">19</span>
                        </div>
                        <div class="progress-bar-container" aria-hidden="true">
                            <div class="progress-bar-fill" style="width: 25%;"></div>
                        </div>
                        <span class="progress-label">Red Blood Cell Disorders</span>
                    </div>
                    
                    <a href="chapter-06-wbc-disorders.html" class="nav-button nav-button--next" aria-label="Next section">
                        <span class="nav-text">Next</span>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>

            <!-- Breadcrumb -->
            <nav class="breadcrumb" aria-label="Breadcrumb">
                <ol class="breadcrumb-list">
                    <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                    <li class="breadcrumb-item active" aria-current="page">Chapter 5</li>
                </ol>
            </nav>

            <!-- Document Header -->
            <header class="document-header">
                <div class="header-badge">
                    <span class="badge-icon">üî¥</span>
                    <span class="badge-text">Hematology</span>
                </div>
                <h1 class="document-title">Red Blood Cell Disorders</h1>
                <div class="title-meta">
                    <span class="meta-item">
                        <span class="meta-icon">üìÑ</span>
                        <span>Chapter 5</span>
                    </span>
                </div>
            </header>

            <!-- Main Content Area -->
            <div class="content-wrapper">
                
                <!-- Anemia -->
                <section id="anemia" class="content-section">
                    <h2 class="section-title">Anemia</h2>
                    
                    <div class="content-card">
                        <h3 id="anemia-basic-principles">I. Basic Principles</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Reduction in circulating red blood cell (RBC) mass</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Presents with signs and symptoms of hypoxia</p>
                                    <ol>
                                        <li>Weakness, fatigue, and dyspnea</li>
                                        <li>Pale conjunctiva and skin</li>
                                        <li>Headache and lightheadedness</li>
                                        <li>Angina, especially with preexisting coronary artery disease</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Hemoglobin (Hb), hematocrit (Hct), and RBC count are used as surrogates for RBC mass, which is difficult to measure.</p>
                                    <ol>
                                        <li>Anemia is defined as $\text{Hb} < 13.5 \text{ g/dL}$ in males and $< 12.5 \text{ g/dL}$ in females (normal Hb is $13.5-17.5 \text{ g/dL}$ in males and $12.5-16.0 \text{ g/dL}$ in females).</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    Based on mean corpuscular volume (MCV), anemia can be classified as microcytic ($\text{MCV} < 80 \mu\text{m}^3$), normocytic ($\text{MCV} = 80-100 \mu\text{m}^3$), or macrocytic ($\text{MCV} > 100 \mu\text{m}^3$).
                                </div>
                            </li>
                        </ul>
                    </div>
                </section>

                <!-- Microcytic Anemias -->
                <section id="microcytic-anemias" class="content-section">
                    <h2 class="section-title">Microcytic Anemias</h2>

                    <div class="content-card">
                        <h3 id="microcytic-principles">I. Basic Principles</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Anemia with $\text{MCV} < 80 \mu\text{m}^3$</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Microcytic anemias are due to decreased production of hemoglobin.</p>
                                    <ol>
                                        <li>RBC progenitor cells in the bone marrow are large and normally divide multiple times to produce smaller mature cells ($\text{MCV} = 80-100 \mu\text{m}^3$).</li>
                                        <li>Microcytosis is due to an "extra" division which occurs to maintain hemoglobin concentration.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">Hemoglobin is made of heme and globin; heme is composed of iron and protoporphyrin. A decrease in any of these components leads to microcytic anemia.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">Microcytic anemias include (1) iron deficiency anemia, (2) anemia of chronic disease, (3) sideroblastic anemia, and (4) thalassemia.</div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="iron-deficiency">II. Iron Deficiency Anemia</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Due to decreased levels of iron</p>
                                    <ol>
                                        <li>$\downarrow$ iron $\rightarrow$ $\downarrow$ heme $\rightarrow$ $\downarrow$ hemoglobin $\rightarrow$ microcytic anemia</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Most common type of anemia</p>
                                    <ol>
                                        <li>Lack of iron is the most common nutritional deficiency in the world, affecting roughly $1/3$ of world's population.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Iron is consumed in heme (meat-derived) and non-heme (vegetable-derived) forms.</p>
                                    <ol>
                                        <li>Absorption occurs in the duodenum. Enterocytes have heme and non-heme (DMT1) transporters; the heme form is more readily absorbed.</li>
                                        <li>Enterocytes transport iron across the cell membrane into blood via ferroportin.</li>
                                        <li>Transferrin transports iron in the blood and delivers it to liver and bone marrow macrophages for storage.</li>
                                        <li>Stored intracellular iron is bound to ferritin, which prevents iron from forming free radicals via the Fenton reaction.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    <p>Laboratory measurements of iron status</p>
                                    <ol>
                                        <li>Serum iron‚Äîmeasure of iron in the blood</li>
                                        <li>Total iron-binding capacity (TIBC)‚Äîmeasure of transferrin molecules in the blood</li>
                                        <li>% saturation‚Äîpercentage of transferrin molecules that are bound by iron (normal is 33%)</li>
                                        <li>Serum ferritin‚Äîreflects iron stores in macrophages and the liver</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">E</span>
                                <div class="list-content">
                                    <p>Iron deficiency is usually caused by dietary lack or blood loss.</p>
                                    <ol>
                                        <li>Infants‚Äîbreast-feeding (human milk is low in iron)</li>
                                        <li>Children‚Äîpoor diet</li>
                                        <li>Adults (20-50 years)‚Äîpeptic ulcer disease in males and menorrhagia or pregnancy in females</li>
                                        <li>Elderly‚Äîcolon polyps/carcinoma in the Western world; hookworm (<em>Ancylostoma duodenale</em> and <em>Necator americanus</em>) in the developing world</li>
                                        <li>Other causes include malnutrition, malabsorption, and gastrectomy (acid aids iron absorption by maintaining the $Fe^{2+}$ state, which is more readily absorbed than $Fe^{3+}$).</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">F</span>
                                <div class="list-content">
                                    <p>Stages of iron deficiency</p>
                                    <ol>
                                        <li>Storage iron is depleted‚Äî$\downarrow$ ferritin; $\uparrow$ TIBC</li>
                                        <li>Serum iron is depleted‚Äî$\downarrow$ serum iron; $\downarrow$ % saturation</li>
                                        <li>Normocytic anemia‚ÄîBone marrow makes fewer, but normal-sized, RBCs.</li>
                                        <li>Microcytic, hypochromic anemia‚ÄîBone marrow makes smaller and fewer RBCs.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">G</span>
                                <div class="list-content">Clinical features of iron deficiency include anemia, koilonychia, and pica.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">H</span>
                                <div class="list-content">
                                    <p>Laboratory findings include</p>
                                    <ol>
                                        <li>Microcytic, hypochromic RBCs with $\uparrow$ red cell distribution width (RDW, Fig. 5.1)</li>
                                        <li>$\downarrow$ ferritin; $\uparrow$ TIBC; $\downarrow$ serum iron; $\downarrow$ % saturation</li>
                                        <li>$\uparrow$ Free erythrocyte protoporphyrin (FEP)</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">I</span>
                                <div class="list-content">Treatment involves supplemental iron (ferrous sulfate).</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">J</span>
                                <div class="list-content">Plummer-Vinson syndrome is iron deficiency anemia with esophageal web and atrophic glossitis; presents as anemia, dysphagia, and beefy-red tongue</div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="anemia-chronic-disease">III. Anemia of Chronic Disease</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Anemia associated with chronic inflammation (e.g., endocarditis or autoimmune conditions) or cancer; most common type of anemia in hospitalized patients</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Chronic disease results in production of acute phase reactants from the liver, including hepcidin.</p>
                                    <ol>
                                        <li>Hepcidin sequesters iron in storage sites by (1) limiting iron transfer from macrophages to erythroid precursors and (2) suppressing erythropoietin (EPO) production; aim is to prevent bacteria from accessing iron, which is necessary for their survival.</li>
                                        <li>$\downarrow$ available iron $\rightarrow$ $\downarrow$ heme $\rightarrow$ $\downarrow$ hemoglobin $\rightarrow$ microcytic anemia</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Laboratory findings include</p>
                                    <ol>
                                        <li>$\uparrow$ ferritin, $\downarrow$ TIBC, $\downarrow$ serum iron, and $\downarrow$ % saturation</li>
                                        <li>$\uparrow$ Free erythrocyte protoporphyrin (FEP)</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">Treatment involves addressing the underlying cause.</div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="sideroblastic-anemia">IV. Sideroblastic Anemia</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Anemia due to defective protoporphyrin synthesis</p>
                                    <ol>
                                        <li>$\downarrow$ protoporphyrin $\rightarrow$ $\downarrow$ heme $\rightarrow$ $\downarrow$ hemoglobin $\rightarrow$ microcytic anemia</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Protoporphyrin is synthesized via a series of reactions.</p>
                                    <ol>
                                        <li>Aminolevulinic acid synthetase (ALAS) converts succinyl CoA to aminolevulinic acid (ALA) using vitamin B6 as a cofactor (rate-limiting step).</li>
                                        <li>Aminolevulinic acid dehydratase (ALAD) converts ALA to porphobilinogen.</li>
                                        <li>Additional reactions convert porphobilinogen to protoporphyrin.</li>
                                        <li>Ferrochelatase attaches protoporphyrin to iron to make heme (final reaction; occurs in the mitochondria).</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Iron is transferred to erythroid precursors and enters the mitochondria to form heme. If protoporphyrin is deficient, iron remains trapped in mitochondria.</p>
                                    <ol>
                                        <li>Iron-laden mitochondria form a ring around the nucleus of erythroid precursors; these cells are called ringed sideroblasts (hence, the term sideroblastic anemia, Fig. 5.2).</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    <p>Sideroblastic anemia can be congenital or acquired.</p>
                                    <ol>
                                        <li>Congenital defect most commonly involves ALAS (rate-limiting enzyme).</li>
                                        <li>Acquired causes include
                                            <ol type="i">
                                                <li>Alcoholism‚Äîmitochondrial poison</li>
                                                <li>Lead poisoning‚Äîinhibits ALAD and ferrochelatase</li>
                                                <li>Vitamin B6 deficiency‚Äîrequired cofactor for ALAS; most commonly seen as a side effect of isoniazid treatment for tuberculosis</li>
                                            </ol>
                                        </li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">E</span>
                                <div class="list-content">Laboratory findings include $\uparrow$ ferritin, $\downarrow$ TIBC, $\uparrow$ serum iron, and $\uparrow$ % saturation (iron-overloaded state).</div>
                            </li>
                        </ul>

                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../../../../../assets/images/image-20251213-5c4e8825.jpeg" 
                                     alt="Microcytic hypochromic RBCs and Ringed sideroblasts" 
                                     class="figure-image"
                                     loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 5.1 Microcytic, hypochromic RBCs of iron deficiency anemia. Fig. 5.2 Ringed sideroblasts (Prussian blue stain).</figcaption>
                        </figure>
                    </div>

                    <div class="content-card">
                        <h3 id="thalassemia">V. Thalassemia</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Anemia due to decreased synthesis of the globin chains of hemoglobin</p>
                                    <ol>
                                        <li>$\downarrow$ globin $\rightarrow$ $\downarrow$ hemoglobin $\rightarrow$ microcytic anemia</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">Inherited mutation; carriers are protected against <em>Plasmodium falciparum</em> malaria.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Divided into $\alpha$- and $\beta$-thalassemia based on decreased production of alpha or beta globin chains.</p>
                                    <ol>
                                        <li>Normal types of hemoglobin are $\text{HbF} (\alpha_2\gamma_2)$, $\text{HbA} (\alpha_2\beta_2)$, and $\text{HbA}_2 (\alpha_2\delta_2)$.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    <p>$\alpha$-Thalassemia is usually due to gene deletion; normally, 4 alpha genes are present on chromosome 16.</p>
                                    <ol>
                                        <li>One gene deleted‚Äîasymptomatic</li>
                                        <li>Two genes deleted‚Äîmild anemia with $\uparrow$ RBC count; cis deletion is associated with an increased risk of severe thalassemia in offspring.
                                            <ol type="i">
                                                <li>Cis deletion is when both deletions occur on the same chromosome; seen in Asians</li>
                                                <li>Trans deletion is when one deletion occurs on each chromosome; seen in Africans, including African Americans</li>
                                            </ol>
                                        </li>
                                        <li>Three genes deleted‚Äîsevere anemia; $\beta$ chains form tetramers (HbH) that damage RBCs; HbH is seen on electrophoresis.</li>
                                        <li>Four genes deleted‚Äîlethal in utero (hydrops fetalis); $\gamma$ chains form tetramers (Hb Barts) that damage RBCs; Hb Barts is seen on electrophoresis.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">E</span>
                                <div class="list-content">
                                    <p>$\beta$-Thalassemia is usually due to gene mutations (point mutations in promoter or splicing sites); seen in individuals of African and Mediterranean descent</p>
                                    <ol>
                                        <li>Two $\beta$ genes are present on chromosome 11; mutations result in absent ($\beta^0$) or diminished ($\beta^+$) production of the $\beta$-globin chain.</li>
                                        <li>$\beta$-Thalassemia minor ($\beta/\beta^+$) is the mildest form of disease and is usually asymptomatic with an increased RBC count.
                                            <ol type="i">
                                                <li>Microcytic, hypochromic RBCs and target cells are seen on blood smear (Fig. 5.3).</li>
                                                <li>Hemoglobin electrophoresis shows slightly decreased HbA with increased $\text{HbA}_2$ (5%, normal 2.5%) and $\text{HbF}$ (2%, normal 1%).</li>
                                            </ol>
                                        </li>
                                        <li>$\beta$-Thalassemia major ($\beta^0/\beta^0$) is the most severe form of disease and presents with severe anemia a few months after birth; high $\text{HbF} (\alpha_2\gamma_2)$ at birth is temporarily protective.
                                            <ol type="i">
                                                <li>Unpaired $\alpha$ chains precipitate and damage RBC membrane, resulting in ineffective erythropoiesis and extravascular hemolysis (removal of circulating RBCs by the spleen).</li>
                                                <li>Massive erythroid hyperplasia ensues resulting in (1) expansion of hematopoiesis into the skull (reactive bone formation leads to 'crewcut' appearance on x-ray, Fig. 5.4) and facial bones ('chipmunk facies'), (2) extramedullary hematopoiesis with hepatosplenomegaly, and (3) risk of aplastic crisis with parvovirus B19 infection of erythroid precursors.</li>
                                                <li>Chronic transfusions are often necessary; leads to risk for secondary hemochromatosis</li>
                                                <li>Smear shows microcytic, hypochromic RBCs with target cells and nucleated red blood cells.</li>
                                                <li>Electrophoresis shows $\text{HbA}_2$ and HbF with little or no HbA.</li>
                                            </ol>
                                        </li>
                                    </ol>
                                </div>
                            </li>
                        </ul>

                        <!-- Table 5.1 -->
                        <div class="table-wrapper">
                            <div class="table-header">
                                <span class="table-icon">üß™</span>
                                <span class="table-caption">Table 5.1: Laboratory Findings in Microcytic Anemia</span>
                            </div>
                            <div class="table-container">
                                <table class="content-table">
                                    <thead>
                                        <tr>
                                            <th>STATE</th>
                                            <th>FERRITIN</th>
                                            <th>TIBC</th>
                                            <th>SERUM IRON</th>
                                            <th>% SATURATION</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td>Normal</td>
                                            <td>-</td>
                                            <td>$300 \mu\text{g/dL}$</td>
                                            <td>$100 \mu\text{g/dL}$</td>
                                            <td>$33\%$</td>
                                        </tr>
                                        <tr>
                                            <td>Iron Deficiency Anemia</td>
                                            <td>Low</td>
                                            <td>High</td>
                                            <td>Low</td>
                                            <td>Low</td>
                                        </tr>
                                        <tr>
                                            <td>Anemia of Chronic Disease</td>
                                            <td>High</td>
                                            <td>Low</td>
                                            <td>Low</td>
                                            <td>Low</td>
                                        </tr>
                                        <tr>
                                            <td>Sideroblastic Anemia</td>
                                            <td>High</td>
                                            <td>Low</td>
                                            <td>High</td>
                                            <td>High</td>
                                        </tr>
                                        <tr>
                                            <td>Pregnancy and oral contraceptives</td>
                                            <td>-</td>
                                            <td>High</td>
                                            <td>-</td>
                                            <td>Low</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                        
                        <div class="figure-grid">
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251213-712a70a1.jpeg" 
                                         alt="Target cells in blood smear" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 5.3 Target cells.</figcaption>
                            </figure>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../../assets/images/image-20251213-32104df8.jpeg" 
                                         alt="Crewcut appearance on skull x-ray" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 5.4 'Crewcut' appearance. (Reproduced with permission, www.orthopaedia.com/x/xgGvAQ)</figcaption>
                            </figure>
                        </div>
                    </div>
                </section>

                <!-- Macrocytic Anemia -->
                <section id="macrocytic-anemia" class="content-section">
                    <h2 class="section-title">Macrocytic Anemia</h2>

                    <div class="content-card">
                        <h3 id="macro-basic-principles">I. Basic Principles</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Anemia with $\text{MCV} > 100 \mu\text{m}^3$; most commonly due to folate or vitamin B12 deficiency (megaloblastic anemia)</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Folate and vitamin B12 are necessary for synthesis of DNA precursors.</p>
                                    <ol>
                                        <li>Folate circulates in the serum as methyltetrahydrofolate (methyl THF); removal of the methyl group allows for participation in the synthesis of DNA precursors.</li>
                                        <li>Methyl group is transferred to vitamin B12 (cobalamin).</li>
                                        <li>Vitamin B12 then transfers it to homocysteine, producing methionine.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Lack of folate or vitamin B12 impairs synthesis of DNA precursors.</p>
                                    <ol>
                                        <li>Impaired division and enlargement of RBC precursors leads to megaloblastic anemia.</li>
                                        <li>Impaired division of granulocytic precursors leads to hypersegmented neutrophils.</li>
                                        <li>Megaloblastic change is also seen in rapidly-dividing (e.g., intestinal) epithelial cells.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">Other causes of macrocytic anemia (without megaloblastic change) include alcoholism, liver disease, and drugs (e.g., 5-FU).</div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="folate-deficiency">II. Folate Deficiency</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Dietary folate is obtained from green vegetables and some fruits.</p>
                                    <ol>
                                        <li>Absorbed in the jejunum</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">Folate deficiency develops within months, as body stores are minimal.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">Causes include poor diet (e.g., alcoholics and elderly), increased demand (e.g., pregnancy, cancer, and hemolytic anemia), and folate antagonists (e.g., methotrexate, which inhibits dihydrofolate reductase).</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    <p>Clinical and laboratory findings include</p>
                                    <ol>
                                        <li>Macrocytic RBCs and hypersegmented neutrophils ($> 5$ lobes, Fig. 5.5)</li>
                                        <li>Glossitis</li>
                                        <li>$\downarrow$ serum folate</li>
                                        <li>$\uparrow$ serum homocysteine (increases risk for thrombosis)</li>
                                        <li>Normal methylmalonic acid</li>
                                    </ol>
                                </div>
                            </li>
                        </ul>
                        
                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../../../../../assets/images/image-20251213-eac96737.jpeg" 
                                     alt="Hypersegmented neutrophil" 
                                     class="figure-image"
                                     loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 5.5 Hypersegmented neutrophil in macrocytic anemia.</figcaption>
                        </figure>
                    </div>

                    <div class="content-card">
                        <h3 id="b12-deficiency">III. Vitamin B12 Deficiency</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Dietary vitamin B12 is complexed to animal-derived proteins.</p>
                                    <ol>
                                        <li>Salivary gland enzymes (e.g., amylase) liberate vitamin B12, which is then bound by R-binder (also from the salivary gland) and carried through the stomach.</li>
                                        <li>Pancreatic proteases in the duodenum detach vitamin B12 from R-binder.</li>
                                        <li>Vitamin B12 binds intrinsic factor (made by gastric parietal cells) in the small bowel; the intrinsic factor-vitamin B12 complex is absorbed in the ileum.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">Vitamin B12 deficiency is less common than folate deficiency and takes years to develop due to large hepatic stores of vitamin B12.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Pernicious anemia is the most common cause of vitamin B12 deficiency.</p>
                                    <ol>
                                        <li>Autoimmune destruction of parietal cells (body of stomach) leads to intrinsic factor deficiency</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">Other causes of vitamin B12 deficiency include pancreatic insufficiency and damage to the terminal ileum (e.g., Crohn disease or <em>Diphyllobothrium latum</em> [fish tapeworm]); dietary deficiency is rare, except in vegans.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">E</span>
                                <div class="list-content">
                                    <p>Clinical and laboratory findings include</p>
                                    <ol>
                                        <li>Macrocytic RBCs with hypersegmented neutrophils</li>
                                        <li>Glossitis</li>
                                        <li>Subacute combined degeneration of the spinal cord
                                            <ol type="i">
                                                <li>Vitamin B12 is a cofactor for the conversion of methylmalonic acid to succinyl CoA (important in fatty acid metabolism).</li>
                                                <li>Vitamin B12 deficiency results in increased levels of methylmalonic acid, which impairs spinal cord myelinization.</li>
                                                <li>Damage results in poor proprioception and vibratory sensation (posterior column) and spastic paresis (lateral corticospinal tract).</li>
                                            </ol>
                                        </li>
                                        <li>$\downarrow$ serum vitamin B12</li>
                                        <li>$\uparrow$ serum homocysteine (similar to folate deficiency), which increases risk for thrombosis</li>
                                        <li>$\uparrow$ methylmalonic acid (unlike folate deficiency)</li>
                                    </ol>
                                </div>
                            </li>
                        </ul>
                    </div>
                </section>

                <!-- Normocytic Anemia -->
                <section id="normocytic-anemia" class="content-section">
                    <h2 class="section-title">Normocytic Anemia</h2>

                    <div class="content-card">
                        <h3 id="normo-basic-principles">I. Basic Principles</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Anemia with normal-sized RBCs ($\text{MCV} = 80-100 \mu\text{m}^3$)</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Due to increased peripheral destruction or underproduction</p>
                                    <ol>
                                        <li>Reticulocyte count helps to distinguish between these two etiologies.</li>
                                    </ol>
                                </div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="reticulocytes">II. Reticulocytes</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Young RBCs released from the bone marrow</p>
                                    <ol>
                                        <li>Identified on blood smear as larger cells with bluish cytoplasm (due to residual RNA, Fig. 5.6)</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Normal reticulocyte count (RC) is $1-2\%$.</p>
                                    <ol>
                                        <li>RBC lifespan is 120 days; each day roughly $1-2\%$ of RBCs are removed from circulation and replaced by reticulocytes.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">A properly functioning marrow responds to anemia by increasing the RC to $>3\%$.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    <p>RC, however, is falsely elevated in anemia.</p>
                                    <ol>
                                        <li>RC is measured as percentage of total RBCs; decrease in total RBCs falsely elevates percentage of reticulocytes.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">E</span>
                                <div class="list-content">
                                    <p>RC is corrected by multiplying reticulocyte count by $\text{Hct}/45$.</p>
                                    <ol>
                                        <li>Corrected count $>3\%$ indicates good marrow response and suggests peripheral destruction.</li>
                                        <li>Corrected count $<3\%$ indicates poor marrow response and suggests underproduction.</li>
                                    </ol>
                                </div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="hemolysis">III. Peripheral RBC Destruction (Hemolysis)</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Divided into extravascular and intravascular hemolysis; both result in anemia with a good marrow response.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Extravascular hemolysis involves RBC destruction by the reticuloendothelial system (macrophages of the spleen, liver, and lymph nodes).</p>
                                    <ol>
                                        <li>Macrophages consume RBCs and break down hemoglobin.
                                            <ol type="i">
                                                <li>Globin is broken down into amino acids.</li>
                                                <li>Heme is broken down into iron and protoporphyrin; iron is recycled.</li>
                                                <li>Protoporphyrin is broken down into unconjugated bilirubin, which is bound to serum albumin and delivered to the liver for conjugation and excretion into bile.</li>
                                            </ol>
                                        </li>
                                        <li>Clinical and laboratory findings include
                                            <ol type="i">
                                                <li>Anemia with splenomegaly, jaundice due to unconjugated bilirubin, and increased risk for bilirubin gallstones</li>
                                                <li>Marrow hyperplasia with corrected reticulocyte count $>3\%$</li>
                                            </ol>
                                        </li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Intravascular hemolysis involves destruction of RBCs within vessels.</p>
                                    <ol>
                                        <li>Clinical and laboratory findings include
                                            <ol type="i">
                                                <li>Hemoglobinemia</li>
                                                <li>Hemoglobinuria</li>
                                                <li>Hemosiderinuria‚ÄîRenal tubular cells pick up some of the hemoglobin that is filtered into the urine and break it down into iron, which accumulates as hemosiderin; tubular cells are eventually shed resulting in hemosiderinuria.</li>
                                                <li>Decreased serum haptoglobin</li>
                                            </ol>
                                        </li>
                                    </ol>
                                </div>
                            </li>
                        </ul>
                    </div>
                </section>

                <!-- Extravascular Hemolysis -->
                <section id="extravascular-hemolysis" class="content-section">
                    <h2 class="section-title">Normocytic Anemias with Predominant Extravascular Hemolysis</h2>

                    <div class="content-card">
                        <h3 id="hereditary-spherocytosis">I. Hereditary Spherocytosis</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Inherited defect of RBC cytoskeleton-membrane tethering proteins</p>
                                    <ol>
                                        <li>Most commonly involves ankyrin, spectrin, or band 3</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Membrane blebs are formed and lost over time.</p>
                                    <ol>
                                        <li>Loss of membrane renders cells round (spherocytes) instead of disc-shaped.</li>
                                        <li>Spherocytes are less able to maneuver through splenic sinusoids and are consumed by splenic macrophages, resulting in anemia.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Clinical and laboratory findings include</p>
                                    <ol>
                                        <li>Spherocytes with loss of central pallor (Fig. 5.7)</li>
                                        <li>$\uparrow$ RDW and $\uparrow$ mean corpuscular hemoglobin concentration (MCHC)</li>
                                        <li>Splenomegaly, jaundice with unconjugated bilirubin, and increased risk for bilirubin gallstones (extravascular hemolysis)</li>
                                        <li>Increased risk for aplastic crisis with parvovirus B19 infection of erythroid precursors</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">Diagnosed by osmotic fragility test, which reveals increased spherocyte fragility in hypotonic solution</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">E</span>
                                <div class="list-content">Treatment is splenectomy; anemia resolves, but spherocytes persist and Howell-Jolly bodies (fragments of nuclear material in RBCs) emerge on blood smear (Fig. 5.8).</div>
                            </li>
                        </ul>

                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../../../../../assets/images/image-20251213-940b4980.jpeg" 
                                     alt="Reticulocyte and Spherocytes" 
                                     class="figure-image"
                                     loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 5.6 Reticulocyte. Fig. 5.7 Spherocytes.</figcaption>
                        </figure>

                         <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../../../../../assets/images/image-20251213-0953bbba.jpeg" 
                                     alt="Howell-Jolly body, Sickle cells, and Hemoglobin C crystal" 
                                     class="figure-image"
                                     loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 5.8 Fragment of nuclear remnant (Howell-Jolly body) within RBC. Fig. 5.9 Sickle cell disease. Fig. 5.10 Hemoglobin C crystal.</figcaption>
                        </figure>
                    </div>

                    <div class="content-card">
                        <h3 id="sickle-cell">II. Sickle Cell Anemia</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Autosomal recessive mutation in $\beta$ chain of hemoglobin; a single amino acid change replaces normal glutamic acid (hydrophilic) with valine (hydrophobic).</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">Gene is carried by $10\%$ of individuals of African descent, likely due to protective role against falciparum malaria.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">Sickle cell disease arises when two abnormal $\beta$ genes are present; results in $>90\%$ HbS in RBCs</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    <p>HbS polymerizes when deoxygenated; polymers aggregate into needle-like structures, resulting in sickle cells (Fig. 5.9).</p>
                                    <ol>
                                        <li>Increased risk of sickling occurs with hypoxemia, dehydration, and acidosis.</li>
                                        <li>HbF protects against sickling; high HbF at birth is protective for the first few months of life. Treatment with hydroxyurea increases levels of HbF.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">E</span>
                                <div class="list-content">
                                    <p>Cells continuously sickle and de-sickle while passing through the microcirculation, resulting in complications related to RBC membrane damage.</p>
                                    <ol>
                                        <li>Extravascular hemolysis‚ÄîReticuloendothelial system removes RBCs with damaged membranes, leading to anemia, jaundice with unconjugated hyperbilirubinemia, and increased risk for bilirubin gallstones.</li>
                                        <li>Intravascular hemolysis‚ÄîRBCs with damaged membranes dehydrate, leading to hemolysis with decreased haptoglobin and target cells on blood smear.</li>
                                        <li>Massive erythroid hyperplasia ensues resulting in
                                            <ol type="i">
                                                <li>Expansion of hematopoiesis into the skull ('crewcut' appearance on x-ray) and facial bones ('chipmunk facies')</li>
                                                <li>Extramedullary hematopoiesis with hepatomegaly</li>
                                                <li>Risk of aplastic crisis with parvovirus B19 infection of erythroid precursors</li>
                                            </ol>
                                        </li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">F</span>
                                <div class="list-content">
                                    <p>Extensive sickling leads to complications of vaso-occlusion.</p>
                                    <ol>
                                        <li>Dactylitis‚Äîswollen hands and feet due to vaso-occlusive infarcts in bones; common presenting sign in infants</li>
                                        <li>Autosplenectomy‚Äîshrunken, fibrotic spleen. Consequences include
                                            <ol type="i">
                                                <li>Increased risk of infection with encapsulated organisms such as <em>Streptococcus pneumoniae</em> and <em>Haemophilus influenzae</em> (most common cause of death in children); affected children should be vaccinated by 5 years of age.</li>
                                                <li>Increased risk of <em>Salmonella paratyphi</em> osteomyelitis</li>
                                                <li>Howell-Jolly bodies on blood smear</li>
                                            </ol>
                                        </li>
                                        <li>Acute chest syndrome‚Äîvaso-occlusion in pulmonary microcirculation
                                            <ol type="i">
                                                <li>Presents with chest pain, shortness of breath, and lung infiltrates</li>
                                                <li>Often precipitated by pneumonia</li>
                                                <li>Most common cause of death in adult patients</li>
                                            </ol>
                                        </li>
                                        <li>Pain crisis</li>
                                        <li>Renal papillary necrosis‚Äîresults in gross hematuria and proteinuria</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">G</span>
                                <div class="list-content">
                                    <p>Sickle cell trait is the presence of one mutated and one normal $\beta$ chain; results in $<50\% \text{ HbS}$ in RBCs (HbA is slightly more efficiently produced than HbS)</p>
                                    <ol>
                                        <li>Generally asymptomatic with no anemia; RBCs with $<50\% \text{ HbS}$ do not sickle in vivo except in the renal medulla.
                                            <ol type="i">
                                                <li>Extreme hypoxia and hypertonicity of the medulla cause sickling, which results in microinfarctions leading to microscopic hematuria and, eventually, decreased ability to concentrate urine.</li>
                                            </ol>
                                        </li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">H</span>
                                <div class="list-content">
                                    <p>Laboratory findings</p>
                                    <ol>
                                        <li>Sickle cells and target cells are seen on blood smear in sickle cell disease, but not in sickle cell trait.</li>
                                        <li>Metabisulfite screen causes cells with any amount of HbS to sickle; positive in both disease and trait</li>
                                        <li>Hb electrophoresis confirms the presence and amount of HbS.
                                            <ol type="i">
                                                <li>Disease‚Äî90% HbS, 8% HbF, 2% HbA2 (no HbA)</li>
                                                <li>Trait‚Äî55% HbA, 43% HbS, 2% HbA2</li>
                                            </ol>
                                        </li>
                                    </ol>
                                </div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="hemoglobin-c">III. Hemoglobin C</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Autosomal recessive mutation in $\beta$ chain of hemoglobin</p>
                                    <ol>
                                        <li>Normal glutamic acid is replaced by lysine.</li>
                                        <li>Less common than sickle cell disease</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">Presents with mild anemia due to extravascular hemolysis</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">Characteristic HbC crystals are seen in RBCs on blood smear (Fig. 5.10).</div>
                            </li>
                        </ul>
                    </div>
                </section>

                <!-- Intravascular Hemolysis -->
                <section id="intravascular-hemolysis" class="content-section">
                    <h2 class="section-title">Normocytic Anemias with Predominant Intravascular Hemolysis</h2>

                    <div class="content-card">
                        <h3 id="pnh">I. Paroxysmal Nocturnal Hemoglobinuria (PNH)</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Acquired defect in myeloid stem cells resulting in absent glycosylphosphatidylinositol (GPI); renders cells susceptible to destruction by complement</p>
                                    <ol>
                                        <li>Blood cells coexist with complement.</li>
                                        <li>Decay accelerating factor (DAF) on the surface of blood cells protects against complement-mediated damage by inhibiting C3 convertase.</li>
                                        <li>DAF is secured to the cell membrane by GPI (an anchoring glycolipid).</li>
                                        <li>Absence of GPI leads to absence of DAF, rendering cells susceptible to complement-mediated damage.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Intravascular hemolysis occurs episodically, often at night during sleep.</p>
                                    <ol>
                                        <li>Mild respiratory acidosis develops with shallow breathing during sleep and activates complement.</li>
                                        <li>RBCs, WBCs, and platelets are lysed.</li>
                                        <li>Intravascular hemolysis leads to hemoglobinemia and hemoglobinuria (especially in the morning); hemosiderinuria is seen days after hemolysis.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">Sucrose test is used to screen for disease; confirmatory test is the acidified serum test or flow cytometry to detect lack of CD55 (DAF) on blood cells.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    <p>Main cause of death is thrombosis of the hepatic, portal, or cerebral veins.</p>
                                    <ol>
                                        <li>Destroyed platelets release cytoplasmic contents into circulation, inducing thrombosis.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">E</span>
                                <div class="list-content">Complications include iron deficiency anemia (due to chronic loss of hemoglobin in the urine) and acute myeloid leukemia (AML), which develops in 10% of patients.</div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="g6pd-deficiency">II. Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>X-linked recessive disorder resulting in reduced half-life of G6PD; renders cells susceptible to oxidative stress</p>
                                    <ol>
                                        <li>RBCs are normally exposed to oxidative stress, in particular $H_2O_2$.</li>
                                        <li>Glutathione (an antioxidant) neutralizes $H_2O_2$, but becomes oxidized in the process.</li>
                                        <li>NADPH, a by-product of G6PD, is needed to regenerate reduced glutathione.</li>
                                        <li>$\downarrow \text{G6PD} \rightarrow \downarrow \text{NADPH} \rightarrow \downarrow$ reduced glutathione $\rightarrow$ oxidative injury by $H_2O_2 \rightarrow$ intravascular hemolysis</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>G6PD deficiency has two major variants.</p>
                                    <ol>
                                        <li>African variant‚Äîmildly reduced half-life of G6PD leading to mild intravascular hemolysis with oxidative stress</li>
                                        <li>Mediterranean variant‚Äîmarkedly reduced half-life of G6PD leading to marked intravascular hemolysis with oxidative stress</li>
                                        <li>High carrier frequency in both populations is likely due to protective role against falciparum malaria.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>Oxidative stress precipitates Hb as Heinz bodies.</p>
                                    <ol>
                                        <li>Causes of oxidative stress include infections, drugs (e.g., primaquine, sulfa drugs, and dapsone), and fava beans.</li>
                                        <li>Heinz bodies are removed from RBCs by splenic macrophages, resulting in bite cells (Fig. 5.11).</li>
                                        <li>Leads to predominantly intravascular hemolysis</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">Presents with hemoglobinuria and back pain hours after exposure to oxidative stress</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">E</span>
                                <div class="list-content">Heinz preparation is used to screen for disease (precipitated hemoglobin can only be seen with a special Heinz stain, Fig. 5.12); enzyme studies confirm deficiency (performed weeks after hemolytic episode resolves).</div>
                            </li>
                        </ul>

                        <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../../../../../assets/images/image-20251213-b5fe89ee.jpeg" 
                                     alt="Bite cell, Heinz bodies, and Schistocyte" 
                                     class="figure-image"
                                     loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 5.11 Bite cell. Fig. 5.12 Heinz bodies (Heinz preparation). Fig. 5.13 Schistocyte.</figcaption>
                        </figure>
                    </div>

                    <div class="content-card">
                        <h3 id="iha">III. Immune Hemolytic Anemia (IHA)</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Antibody-mediated (IgG or IgM) destruction of RBCs</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>IgG-mediated disease usually involves extravascular hemolysis.</p>
                                    <ol>
                                        <li>IgG binds RBCs in the relatively warm temperature of the central body (warm agglutinin); membrane of antibody-coated RBC is consumed by splenic macrophages, resulting in spherocytes.</li>
                                        <li>Associated with SLE (most common cause), CLL, and certain drugs (classically, penicillin and cephalosporins)
                                            <ol type="i">
                                                <li>Drug may attach to RBC membrane (e.g., penicillin) with subsequent binding of antibody to drug-membrane complex</li>
                                                <li>Drug may induce production of autoantibodies (e.g., $\alpha$-methyldopa) that bind self antigens on RBCs</li>
                                            </ol>
                                        </li>
                                        <li>Treatment involves cessation of the offending drug, steroids, IVIG, and, if necessary, splenectomy.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">
                                    <p>IgM-mediated disease can lead to intravascular hemolysis.</p>
                                    <ol>
                                        <li>IgM binds RBCs and fixes complement in the relatively cold temperature of the extremities (cold agglutinin).</li>
                                        <li>RBCs inactivate complement, but residual C3b serves as an opsonin for splenic macrophages resulting in spherocytes; extreme activation of complement can lead to intravascular hemolysis.</li>
                                        <li>Associated with <em>Mycoplasma pneumoniae</em> and infectious mononucleosis.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    <p>Coombs test is used to diagnose IHA; testing can be direct or indirect.</p>
                                    <ol>
                                        <li>Direct Coombs test confirms the presence of antibody- or complement-coated RBCs. When anti-IgG/complement is added to patient RBCs, agglutination occurs if RBCs are already coated with IgG or complement. This is the most important test for IHA.</li>
                                        <li>Indirect Coombs test confirms the presence of antibodies in patient serum. Anti-IgG and test RBCs are mixed with the patient serum; agglutination occurs if serum antibodies are present.</li>
                                    </ol>
                                </div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="microangiopathic">IV. Microangiopathic Hemolytic Anemia</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">
                                    <p>Intravascular hemolysis that results from vascular pathology; RBCs are destroyed as they pass through the circulation.</p>
                                    <ol>
                                        <li>Iron deficiency anemia occurs with chronic hemolysis.</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">Occurs with microthrombi (TTP-HUS, DIC, HELLP), prosthetic heart valves, and aortic stenosis; when present, microthrombi produce schistocytes on blood smear (Fig. 5.13).</div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="malaria">V. Malaria</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Infection of RBCs and liver with <em>Plasmodium</em> (Fig. 5.14); transmitted by the female <em>Anopheles</em> mosquito</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>RBCs rupture as a part of the <em>Plasmodium</em> life cycle, resulting in intravascular hemolysis and cyclical fever.</p>
                                    <ol>
                                        <li><em>P falciparum</em>‚Äîdaily fever</li>
                                        <li><em>P vivax</em> and <em>P ovale</em>‚Äîfever every other day</li>
                                    </ol>
                                </div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">Spleen also consumes some infected RBCs; results in mild extravascular hemolysis with splenomegaly</div>
                            </li>
                        </ul>

                         <figure class="content-figure" data-lightbox="true">
                            <div class="figure-image-wrapper">
                                <img src="../../../../../assets/images/image-20251213-d505df84.jpeg" 
                                     alt="Erythrocytes infected with P falciparum and Aplastic anemia marrow" 
                                     class="figure-image"
                                     loading="lazy">
                                <div class="figure-overlay">
                                    <span class="overlay-icon">üîç</span>
                                    <span class="overlay-text">Click to enlarge</span>
                                </div>
                            </div>
                            <figcaption class="figure-caption">Fig. 5.14 Erythrocytes infected with P falciparum. (Courtesy of Paulo Mourao, MD). Fig. 5.15 Aplastic anemia.</figcaption>
                        </figure>
                    </div>
                </section>

                <!-- Anemia due to Underproduction -->
                <section id="anemia-underproduction" class="content-section">
                    <h2 class="section-title">Anemia Due to Underproduction</h2>

                    <div class="content-card">
                        <h3 id="underproduction-principles">I. Basic Principles</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Decreased production of RBCs by bone marrow; characterized by low corrected reticulocyte count</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">
                                    <p>Etiologies include</p>
                                    <ol>
                                        <li>Causes of microcytic and macrocytic anemia</li>
                                        <li>Renal failure‚Äîdecreased production of EPO by peritubular interstitial cells</li>
                                        <li>Damage to bone marrow precursor cells (may result in anemia or pancytopenia)</li>
                                    </ol>
                                </div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="parvovirus-b19">II. Parvovirus B19</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Infects progenitor red cells and temporarily halts erythropoiesis; leads to significant anemia in the setting of preexisting marrow stress (e.g., sickle cell anemia).</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">Treatment is supportive (infection is self-limited).</div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="aplastic-anemia">III. Aplastic Anemia</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Damage to hematopoietic stem cells, resulting in pancytopenia (anemia, thrombocytopenia, and leukopenia) with low reticulocyte count</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">B</span>
                                <div class="list-content">Etiologies include drugs or chemicals, viral infections, and autoimmune damage.</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">C</span>
                                <div class="list-content">Biopsy reveals an empty, fatty marrow (Fig. 5.15).</div>
                            </li>
                            <li class="list-item">
                                <span class="list-marker">D</span>
                                <div class="list-content">
                                    <p>Treatment includes cessation of any causative drugs and supportive care with transfusions and marrow-stimulating factors (e.g., erythropoietin, GM-CSF, and G-CSF).</p>
                                    <ol>
                                        <li>Immunosuppression may be helpful as some idiopathic cases are due to abnormal T-cell activation with release of cytokines.</li>
                                        <li>May require bone marrow transplantation as a last resort</li>
                                    </ol>
                                </div>
                            </li>
                        </ul>
                    </div>

                    <div class="content-card">
                        <h3 id="myelophthisic">IV. Myelophthisic Process</h3>
                        <ul class="enhanced-list">
                            <li class="list-item">
                                <span class="list-marker">A</span>
                                <div class="list-content">Pathologic process (e.g., metastatic cancer) that replaces bone marrow; hematopoiesis is impaired, resulting in pancytopenia.</div>
                            </li>
                        </ul>
                    </div>
                </section>
            </div>

            <!-- Bottom Navigation -->
            <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                <div class="nav-container">
                    <a href="chapter-04-hemostasis.html" class="nav-button nav-button--prev nav-button--large">
                        <span class="nav-icon">‚Üê</span>
                        <div class="nav-content">
                            <span class="nav-label">Previous</span>
                            <span class="nav-title">Hemostasis and Related Disorders</span>
                        </div>
                    </a>
                    
                    <a href="../index.html" class="nav-button nav-button--toc">
                        <span class="nav-icon">üìö</span>
                        <span class="nav-text">All Topics</span>
                    </a>
                    
                    <a href="chapter-06-wbc-disorders.html" class="nav-button nav-button--next nav-button--large">
                        <div class="nav-content">
                            <span class="nav-label">Next</span>
                            <span class="nav-title">White Blood Cell Disorders</span>
                        </div>
                        <span class="nav-icon">‚Üí</span>
                    </a>
                </div>
            </nav>
        </article>
    </div>
</div>

<!-- Lightbox Modal -->
<div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
    <div class="lightbox-backdrop"></div>
    <div class="lightbox-content">
        <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
        <img class="lightbox-image" src="" alt="">
        <p class="lightbox-caption"></p>
    </div>
</div>

<!-- JavaScript Dependencies -->
<script src="../js/theme.js"></script>
<script src="../js/navigation.js"></script>
<script src="../js/interactions.js"></script>